Matthew Stanton
Stock Analyst at Jefferies
(0.31)
# 3,147
Out of 4,415 analysts
4
Total ratings
n/a
Success rate
-7.75%
Average return
Main Sectors:
4 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CYRX Cryoport | Assumes: Buy | $17 → $21 | $17.16 | +22.38% | 1 | Apr 4, 2024 | |
| LAB Standard BioTools | Initiates: Buy | $3.25 | $2.53 | +28.46% | 1 | Apr 4, 2024 | |
| BLFS BioLife Solutions | Initiates: Buy | $22 | $18.16 | +21.15% | 1 | Apr 4, 2024 | |
| AZTA Azenta | Initiates: Hold | $64 | $52.57 | +21.74% | 1 | Apr 4, 2024 |
Cryoport
Apr 4, 2024
Assumes: Buy
Price Target: $17 → $21
Current: $17.16
Upside: +22.38%
Standard BioTools
Apr 4, 2024
Initiates: Buy
Price Target: $3.25
Current: $2.53
Upside: +28.46%
BioLife Solutions
Apr 4, 2024
Initiates: Buy
Price Target: $22
Current: $18.16
Upside: +21.15%
Azenta
Apr 4, 2024
Initiates: Hold
Price Target: $64
Current: $52.57
Upside: +21.74%